Latest news
MEDIA RELEASE: Oct 04, 2022 09:09 AM
Higher body temperature alters key protein in autoinflammato...
Groundbreaking research offers insights into understanding the inflammatory disorder mevalonate kinase deficiency, and reveals new potential treatment approaches for this devastating disease.
MEDIA RELEASE: Jan 06, 2022 01:37 PM
Common osteoporosis medication boosts immune response in lun...
Researchers have uncovered a mechanism by which bisphosphonates – a treatment commonly prescribed for osteoporosis – may help fight respiratory infections.
Nov 08, 2019 03:34 PM
St Vincent’s Clinic Foundation Grants for Garvan researchers...
Researchers from across the Institute have been awarded seven grants from the St Vincent’s Clinic Foundation.
Mar 29, 2019 09:38 AM
A driver of inflammation in a rare childhood condition
Australian scientists have uncovered part of the process that leads to ‘inflammatory flares’ in patients with a rare immune disorder.
MEDIA RELEASE: May 11, 2017 12:05 AM
Proteins on the loose in a debilitating childhood disease
Australian scientists have shown, for the first time, that a family of untethered proteins builds up in the cells of children with a rare and serious genetic condition, known as mevalonate kinase deficiency (MKD).
MEDIA RELEASE: Dec 04, 2015 09:56 AM
How to wake a sleeping cancer cell – and why you might want ...
Cancer cells that lie ‘snoozing’ in the skeleton can be awakened – or left to slumber on – by changes in the bone that surrounds them, Australian scientists have shown.
MEDIA RELEASE: Nov 06, 2014 04:00 AM
Bone drug should be seen in a new light for its anti-cancer ...
Australian researchers have shown why calcium-binding drugs commonly used to treat people with osteoporosis, or with late-stage cancers that have spread to bone, may also benefit patients with tumours outside the skeleto...